Technology

EClinCloud’s eCOA Platform Reaches 177 Countries and Regions as Multi-Regional Trials Drive Electronic Outcome Capture

Published

4 hours ago

September 30, 2026

The electronic clinical outcome assessment solution now spans 40+ indication areas and 960+ collaborating sites across four continents, supporting all five COA types with end-to-end scale management, rater training and direct EDC integration.

NINGBO, China, Sept. 30, 2026 /PRNewswire/ — EClinCloud, an AI technology company for clinical research that builds a unified clinical cloud platform and endpoint assessment technology to help improve trial success rates and shorten development cycles, today detailed the global reach of its eCOA solution: the company’s electronic clinical outcome assessment application now operates in 177 countries and regions across four continents, with deployments spanning more than 40 indication areas and 960+ collaborating sites. The expansion tracks two reinforcing industry trends — international multi-regional clinical trials (MRCTs) taking an ever-larger share of new drug development, and outcome capture moving steadily from paper to electronic.

The company’s own registry research puts numbers on the multi-regional shift. Its analysis of industry multinational drug-trial starts found China-inclusive MRCTs growing fivefold in a decade, from 65 starts in 2015 to 322 in 2025 — 28.6% of all such starts — with the median China-inclusive MRCT now spanning 15 countries and 90 facilities, against five countries and 27 facilities for multinational trials without China. On the assessment side, among phase 2/3 drug studies that name a widely used outcome instrument on ClinicalTrials.gov, one in three (33.1%) reports recruitment in multiple countries, and the top 1% span 22 countries or more.

The platform captures every major class of clinical outcome assessment on a single system: patient-reported outcomes (ePRO), clinician-reported outcomes (eClinRO), observer-reported outcomes (eObsRO), performance outcomes (ePerfO) and electronic diaries (eDiary). Because each assessment type implies a different workflow — who answers, on what device, on what schedule — running all five through one platform keeps a multi-country study’s endpoint data on one backbone rather than scattered across point tools.

For MRCTs, deployment breadth is the operational test. EClinCloud delivers multilingual assessments in Chinese, English, Japanese and additional languages, including less widely spoken ones, and provides hardware and software as one service — PC, mobile app and tablet working in concert — so sites and patients in every region capture data the same way. The company’s eCOA experience covers indication areas from CNS, oncology and dermatology to immunology, metabolic and endocrine disorders, respiratory disease and otolaryngology.

Privacy and compliance run through the deployment model. The platform is designed to meet the strict patient-privacy requirements of global data-protection regimes — GDPR in Europe, HIPAA in the United States and China’s Personal Information Protection Law (PIPL) — while accommodating the marked differences between countries and regions in data-collection practice, cultural norms and regulatory enforcement, so that studies keep data consistent and compliant across every site.

“In a multi-regional trial, the hard part is no longer collecting a questionnaire — it is keeping every language, every rater and every device consistent and reliable across dozens of countries at once,” said Michael Qin, PhD, Founder and Chief Executive Officer of EClinCloud. “That is why we built eCOA as an integrated solution with scale management, rater training and data connections around it, rather than as a standalone app.”

Around the software, EClinCloud operates end-to-end scale management drawing on a rich scale library and multi-indication experience: scale due diligence, copyright licensing, translation and linguistic validation, and final delivery handled as one integrated workflow — the decision framework behind it is set out in the company’s report “eCOA Linguistic Validation 2026: Translate, Adapt, License or Revalidate for a Multinational Trial?” The registry shows the scale of that work: the company’s analysis found the VAS named in 19,413 registered studies, the EQ-5D in 8,317 and the SF-36 in 6,626, each carrying its own licensing, translation and validation requirements — a single instrument such as the EQ-5D-5L is maintained in more than 150 languages.

Complementing scale management, the company provides rater training to keep assessment results consistent and reliable across sites and raters — the discipline on which multi-regional endpoint quality depends. Its CNS analysis shows the scale of the need: 48.6% of 5,891 phase 2/3 CNS drug trials name a clinician-rated scale in an outcome, and 26.6% report sites in more than one country — and because public registries carry no field for rater qualification, consistency cannot be demonstrated from public records; it has to be built into the trial itself. The certification, inter-rater reliability and drift-monitoring framework behind the service is set out in the company’s report “Clinical Trial Rater Training 2026: Certification, Inter-Rater Reliability and Drift Monitoring for CNS ClinRO Endpoints.”

Assessment data does not sit in a silo. The eCOA platform integrates directly with EDC so endpoint data flows into a single casebook, while BI analytics assemble operational and clinical data into a full-picture view that supports faster, better-informed study decisions. AI-assisted capture adds a quality layer: in one pediatric Phase II study, AI-guided photo capture with real-time validation raised image pass rates from 40% to about 95% and cut rework cycles from 24–48 hours to under five seconds, with automatic privacy redaction at the point of capture.

In summary, the eCOA solution offers sponsors and study principal investigators running multi-regional trials:

All five COA types — ePRO, eClinRO, eObsRO, ePerfO and eDiary — on one platformMultilingual deployment, with the eCOA app available in 177 countries and regions across four continentsExperience across 40+ indication areas and 960+ collaborating sitesUnified hardware-software delivery spanning PC, mobile app and tabletIntegrated scale management: scale due diligence, copyright licensing, translation and linguistic validation, and deliveryRater training that safeguards the consistency and reliability of assessment resultsDirect EDC integration and BI analytics for decision supportPrivacy and compliance by design: built for GDPR, HIPAA and China’s PIPL, bridging country-to-country differences in data-collection practice, culture and regulatory enforcement to keep data consistent and compliant

These capabilities are backed by EClinCloud’s Deep Research series, which publishes the evidence base behind its platform and services. Recent reports also include “Multiregional Clinical Trials With China Sites in 2026: HGR Approval, PIPL Data Export and What the Registries Show,” on the data-governance decisions MRCT sponsors face, with the full series available at https://www.eclincloud.com/insights.

For demonstrations and partnership inquiries, visit https://www.eclincloud.com/demo.

About EClinCloud

EClinCloud (Ningbo) Technology Co., Ltd. builds a unified, AI-driven clinical cloud platform and endpoint assessment technology for global pharmaceutical and research organizations, with a mission to become a global leader in AI-driven clinical research. Its integrated platform — EDC, RTSM, eCOA, IRC, CTMS, eTMF, resource management and eLearning, with embedded AI agents and BI analytics — supports 1,100+ clinical trials, 300+ organizations and 20,000+ users in 10+ countries and regions. EClinCloud is headquartered in Ningbo, China, with offices in Beijing, Shanghai, Chengdu, Shenzhen and New York. More information is available at https://www.eclincloud.com.

Company Contact

EClinCloud — Global Inquiries
EClinCloud (Ningbo) Technology Co., Ltd.
Phone: +86 186 1698 7169
Email: ecc@eclincloud.com
Web: https://www.eclincloud.com/demo

Media Relations

EClinCloud — Press Inquiries
Phone: +1 415 689 1868
Email: press-media@vayomed.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/eclinclouds-ecoa-platform-reaches-177-countries-and-regions-as-multi-regional-trials-drive-electronic-outcome-capture-302894155.html

SOURCE EClinCloud

Technology

From Data to Action: Gong Debuts New Revenue AI Innovation at Celebrate ’26

Published

50 minutes ago

September 30, 2026

Featuring customers & partners from Anthropic, AT&T, Cisco, Snowflake and more showcasing real revenue AI outcomes, and keynote speaker and bestselling author Daniel Pink

LAS VEGAS and SAN FRANCISCO, Sept. 30, 2026 /PRNewswire/ — Gong today unveiled several major revenue AI announcements at Celebrate ’26, its annual customer conference live from Las Vegas. Gong cofounder and CEO Amit Bendov discussed the next evolution of Revenue AI and announced the launch of several new innovations, including Gong Enrich, Agent Builder, and Deep Mode in Gong Assistant. Gong also announced Gong Activate, the next generation of Revenue AI, that allows teams to deploy the motions that win, retain, and grow accounts, with agents and reps all working from the same blueprint.

Introducing Gong Activate
Enterprises are no longer satisfied with evaluating AI; they want scalable results. While modern AI lowers the barrier to automating tasks, without deep contextual intelligence, it can’t be trusted with much of the nuanced work that drives revenue. That’s the backdrop for Gong Activate, centered on Gong’s vision for a self-improving “revenue loop”.

Gong captures your organization’s unique institutional knowledge within the Gong Revenue Graph. From buyer personas and competitive positioning to your best reps’ deal-closing strategies, it creates an ever-improving model of your business.

Gong Activate will convert this into effective action. Always-on agents continuously evaluate every account, opportunity, and revenue play, building detailed prescriptions for the best path forward. This will allow Gong Activate to orchestrate your most valuable revenue work. It delivers up-to-date, highly relevant guidance to team members and provides the context for specialized agents to work alongside them, automating time-consuming steps in full alignment with the plan.

And measurement creates constant feedback, folding outcomes back into the Revenue Graph so every decision and action sharpens the next. The result is a virtuous revenue loop that will help new reps perform like seasoned veterans, build trust in automated workflows, and consistently shift the performance bell curve.

“Gong pioneered Revenue AI in 2015. Today, we’re taking the next step with the announcement of Gong Activate – centered on Gong’s vision for a self-improving revenue loop,” said Amit Bendov, Gong Co-founder and CEO. “For years, AI told you how to win. Now, AI wins deals for you. That means faster cycles, higher win rates, and reps running proven plays instead of guessing.”

New Product Innovations
In addition to Gong Activate, Gong introduced new offerings and enhancements as part of its latest product release, Mission Callisto, built to help revenue teams move faster and with less friction. Highlights include:

Gong Enrich, a new sales enrichment offering, helps close the data gaps that slow sellers down, automatically filling in missing account and contact details so reps spend less time researching and more time acting. Enrich launch partners include Apollo, Findymail, Firmable, Kernel, LeadIQ, Lusha, RocketReach, Wiza, ZeroBounce, and ZoomInfo.Agent Builder enables teams to create custom agents that automatically run in response to the events and conditions they define, helping automate and scale your most critical, winning workflows. Define the triggers, conditions, steps, and actions, or simply describe the agent you want in natural language. Your workflows run consistently across the business whenever the right event occurs, without relying on someone to remember to start them.Deep Mode, an agent within the Gong Assistant, takes on the investigation behind hard business questions, turning what used to take hours of manual digging into a grounded, comprehensive answer.

To learn more about the latest launch and all innovations in Mission Callisto, read more here.

Showcasing customer outcomes
Live on-stage customers like AT&T Business, Anthropic, Cisco, Experian, Snowflake, Thomson Reuters and others shared how they are driving real outcomes with Revenue AI. Highlights included:

AT&T Business is driving better business outcomes with Gong. One example is via coaching. By utilizing scorecards, call reviews, and manager feedback in Gong they achieved a 54% improvement in rep productivity. Additionally, users of the 12 Gong features they are using outperformed the productivity of non-users every time.Cisco returned to the stage a year into their rollout, now with enough scale to measure real outcomes as they have deployed 18,000 Gong licenses company-wide, gained insights from over 450,000 conversations and got their entire salesforce up and running on Gong Engage. This has led to remarkable productivity, including notable incremental revenue from over 50,000 Engage flows executed. Early-adopting teams are showing roughly 32% larger deal sizes and 26% higher win rates.Experian consolidated a division built from four separate acquisitions around one AI-driven platform – not by starting with a tool, but by identifying three specific decisions to improve: coaching, continuity, and renewal risk.The result was a 25% lift in win rates, proof that AI can’t create your strategy; it can only scale it.

Additional Celebrate ’26 Highlights
Celebrate ’26 will feature a keynote from Daniel Pink, #1 New York Times bestselling author of To Sell Is Human, Drive, When, The Power of Regret, and A Whole New Mind. Pink will discuss the 5 Ways to Navigate What’s Next, and will offer a quick look at the big trends reshaping business. He will also share a set of practical, science-based tips for making progress amid the turbulence. Attendees will come away with a clearer framework for persuasion grounded in how people actually think and decide, rather than in sales tricks.

Learn More
For more information on Celebrate ’26 and to watch replays from the event, visit https://www.gong.io/events/celebrate

About Gong
Gong harnesses the power of AI to transform how revenue teams win. Gong Revenue AI unifies data, insights, and workflows into a single, trusted system that observes, guides, and acts alongside the world’s most successful revenue teams. Powered by the Gong Revenue Graph, specialized agents, and trusted applications, Gong helps more than 5,000 organizations around the world deeply understand their teams and customers, automate critical revenue workflows, and close more deals with less effort. Learn more at gong.io.

View original content to download multimedia:https://www.prnewswire.com/news-releases/from-data-to-action-gong-debuts-new-revenue-ai-innovation-at-celebrate-26-302894000.html

SOURCE Gong

Technology

Revenue alai by LateralCare Available on the Microsoft Marketplace

Published

50 minutes ago

September 30, 2026

Microsoft customers worldwide can discover and deploy revenue alai by LateralCare through Microsoft Marketplace, accessing trusted solutions that accelerate innovation and business transformation with unified integration across Microsoft products

DALLAS, Sept. 30, 2026 /PRNewswire/ — LateralCare announced the availability of revenue alai in the Microsoft Marketplace, the unified online destination for customers to buy trusted cloud solutions, AI apps, and agents to meet their business needs. Revenue alai customers can now discover and deploy trusted solutions through Microsoft Marketplace, with smooth integration and streamlined management across Microsoft Azure and other Microsoft products.

LateralCare is a healthcare technology company dedicated to responsibly applying Agentic AI to transform complex healthcare operations. Its AI-native solutions combine intelligent automation, explainable decisioning, and human-in-the-loop governance to help organizations improve efficiency, strengthen performance, and navigate operational complexity with greater confidence. Revenue alai, LateralCare’s flagship platform for revenue cycle management, brings these capabilities to financial operations, helping healthcare organizations reduce administrative burden, improve visibility, and drive stronger outcomes. Through Microsoft Marketplace, organizations can more easily discover, deploy, and integrate revenue alai within their existing Microsoft technology environments.

“The availability of revenue alai through Microsoft Marketplace marks an important milestone in our mission to transform healthcare revenue cycle management through responsible AI,” said William Reau, Chief Executive Officer of LateralCare. “Healthcare organizations need solutions that not only automate work, but also provide transparency, accountability, and measurable impact. Through Microsoft Marketplace, customers can more easily deploy revenue alai within their existing technology ecosystem and leverage AI-driven intelligence to improve revenue performance, reduce operational burden, and support better organizational outcomes.”

“We’re pleased to welcome revenue alai by LateralCare to Microsoft Marketplace,” said Cyril Belikoff, vice president, Microsoft Azure Product Marketing. “Marketplace connects trusted solutions from global partners with customers worldwide, making it easy to find and deploy apps that work seamlessly with Microsoft products.”

Microsoft Marketplace is a single destination to find, try, and buy trusted cloud solutions, AI apps, and agents to meet your business objectives. Choose from a growing collection of solutions tailored to your unique needs, available both in Marketplace and directly within Microsoft products.

About LateralCare
LateralCare is a healthcare technology company dedicated to responsibly integrating Agentic AI to transform complex healthcare operations. Its AI-native flagship platform, revenue alai, modernizes revenue cycle management by uniting intelligent automation with explainable decisioning and human-in-the-loop governance—helping healthcare organizations improve financial performance while operating with greater clarity, confidence, and control.

For more information, visit www.lateralcare.com or follow revenue alai and LateralCare on LinkedIn for the latest updates.

For more information, press only:

Sunya Chandi, LateralCare, sunya@lateralcare.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/revenue-alai-by-lateralcare-available-on-the-microsoft-marketplace-302894434.html

SOURCE LateralCare

Technology

Study Finds Majority of Advertisers Would Pay a Premium for More Audience Choices and Faster Campaign Delivery

Published

50 minutes ago

September 30, 2026

Although most advertisers are bullish on commerce media spending, 86% say slow audience fulfillment could cause them to cut spending or leave a network partner

NEW YORK, Sept. 30, 2026 /PRNewswire/ — GrowthLoop, a pioneer in agentic AI-powered marketing solutions, today released its 2026 Commerce Media Investment Index, revealing that activation speed and audience options have become decisive factors in where advertisers place retail and commerce media budgets. Conducted in partnership with Ascend2, the study surveyed nearly 300 U.S. and Canadian marketing professionals involved in retail media network (RMN) or commerce media network (CMN) advertising decisions.

The findings reveal what motivates advertisers to spend more with network partners and shed light on how execution friction could put that spend at risk:

86% say slow audience fulfillment could cause them to reduce spend or leave a network partner, while 85% say they would pay a premium for same-day fulfillment. Nearly all respondents indicate that access to more segments would make them more likely to increase spend.32% of advertisers have reduced, paused, or reconsidered investment because of difficulty proving ROI to leadership.

“Advertisers are telling media networks how to win more budget: Provide better audiences, activate them faster, and deliver meaningful results quickly enough to inform the next campaign,” said Anthony Rotio, co-founder and co-CEO of GrowthLoop. “As we’ve seen with customers like Gopuff, a warehouse-native audience building solution is the way to fulfill these requirements and ultimately build stronger advertiser relationships.”

Key report findings

The Index shows that advertisers spread significant budget across a crowded commerce media market. The majority of advertisers allocate at least 15% of their digital advertising budgets to these networks and 90% work with two or more RMN or CMN partners. No respondents plan to decrease commerce media spend in the next year, and a full 85% plan to increase their spend.

Additional findings include:

Speed shapes spending decisions

92% would be more likely to increase spend with faster audience fulfillment.94% would likely spend more with partners offering self-service audience-building tools.Advertisers reporting the strongest ROI are five times more likely than others to receive custom audiences the same day.

Advertisers want more audience choice

Only 38% are extremely satisfied with the number of audiences available through their partners.95% say they would be more likely to increase spend with access to more segments.

Confidence in incrementality measurement drives investment and ROI

Only 40% are very confident in their partners’ incrementality measurement.Advertisers with high confidence in their partners’ measurement spend a larger share of their digital budget on RMN/CMN and are more than twice as likely to significantly exceed ROI targets.

Campaign results often arrive too late to guide the next decision

Nearly half of advertisers wait at least one week for post-campaign performance data, while only 8% receive it the same day.Just 32% say they can consistently use campaign results to optimize future audience targeting.

Putting audience scale and speed into practice

As audience speed and scale remain top of mind for advertisers, Gopuff — the leading instant commerce platform that delivers thousands of everyday products to customers in minutes — has shown how media networks can successfully address these priorities. Leveraging a composable commerce media solution, Gopuff can provide brand advertisers with a larger pool of audiences, activate campaigns quickly, and provide faster, more comprehensive visibility into campaign metrics.

“Advertisers increasingly expect both greater audience customization and faster activation, and we no longer have to trade one for the other,” said JR Crosby, director of data partnerships at Gopuff. “After implementing a warehouse-native stack, we increased our audience segments from 100 to more than 600, and expanded audiences for our subsidiary, BevMo!, from 75 to 400. These expanded audience catalogs give our internal teams and brand partners a broader range of ready-to-use targeting options and create the groundwork for more customized segment offerings.”

To download the full 2026 Commerce Media Investment Index, visit go.growthloop.com/cmn-index. To learn more about GrowthLoop’s Composable Commerce Media solution, visit https://www.growthloop.com/teams/commerce-media.

About GrowthLoop

GrowthLoop is a pioneer in composable, AI-powered marketing on the data cloud, featured on G2 by its customers as a momentum leader with the best ROI for enterprise. The GrowthLoop agentic, composable CDP drives compound growth by accelerating the marketing cycle using agentic AI powered by your enterprise cloud data. Working alongside AI agents, teams use GrowthLoop to translate customer data into precise audiences and activate those audiences across real-time customer journeys, measuring and improving performance through always-on analysis — all with zero data movement. Thousands of marketers at enterprises like Costco, Albertsons, Fanatics, and Ford rely on GrowthLoop to bring their AI strategy to life, grow faster with every experiment, personalize every customer touchpoint, and drive rapidly compounding results.

Media Contact

press@growthloop.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/study-finds-majority-of-advertisers-would-pay-a-premium-for-more-audience-choices-and-faster-campaign-delivery-302893521.html

SOURCE GrowthLoop